March 28, 2022 07:20 AM EDT
Pharma

Ver­tex strikes agree­ment with Aus­tralia for cys­tic fi­bro­sis pill, end­ing high-pro­file stand­off

Jason Mast

Editor

Ver­tex reached an agree­ment on Sun­day to sell its newest cys­tic fi­bro­sis drug in Aus­tralia, end­ing a high-pro­file stand­off over ac­cess to a life-al­ter­ing but …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

In a blow to its obe­si­ty pipeline, Pfiz­er drops oral drug af­ter liv­er in­jury case

Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

Eli Lil­ly re­ports first Phase 3 da­ta for oral GLP-1, post­ing a win in di­a­betes

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times